BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19446763)

  • 1. Modeling and prediction of cocrystal phase diagrams.
    Ainouz A; Authelin JR; Billot P; Lieberman H
    Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
    Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
    Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the phase behavior in mixtures of pharmaceuticals with liquid or supercritical solvents.
    Tsivintzelis I; Economou IG; Kontogeorgis GM
    J Phys Chem B; 2009 May; 113(18):6446-58. PubMed ID: 19368360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds.
    Nordström FL; Rasmuson AC
    Eur J Pharm Sci; 2009 Feb; 36(2-3):330-44. PubMed ID: 19022383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.
    van Eupen JT; Westheim R; Deij MA; Meekes H; Bennema P; Vlieg E
    Int J Pharm; 2009 Feb; 368(1-2):146-53. PubMed ID: 18996456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the phase diagrams of chiral praziquantel.
    Liu Y; Wang X; Wang JK; Ching CB
    Chirality; 2006 May; 18(4):259-64. PubMed ID: 16521119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico prediction of drug solubility: 4. Will simple potentials suffice?
    Lüder K; Lindfors L; Westergren J; Nordholm S; Persson R; Pedersen M
    J Comput Chem; 2009 Sep; 30(12):1859-71. PubMed ID: 19115279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
    Kalogeras IM
    Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
    Amharar Y; Curtin V; Gallagher KH; Healy AM
    Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling, solubility and pK(a) of five sparingly soluble drugs.
    Domańska U; Pobudkowska A; Pelczarska A; Zukowski L
    Int J Pharm; 2011 Jan; 403(1-2):115-22. PubMed ID: 21034801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliquescence of pharmaceutical systems.
    Mauer LJ; Taylor LS
    Pharm Dev Technol; 2010 Dec; 15(6):582-94. PubMed ID: 19895256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.
    Ruether F; Sadowski G
    J Pharm Sci; 2009 Nov; 98(11):4205-15. PubMed ID: 19283772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles.
    Morrison HG; Sun CC; Neervannan S
    Int J Pharm; 2009 Aug; 378(1-2):136-9. PubMed ID: 19477257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.
    Abramov YA; Loschen C; Klamt A
    J Pharm Sci; 2012 Oct; 101(10):3687-97. PubMed ID: 22821740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of drug solubility in water-dioxane mixtures using the Jouyban-Acree model.
    Jouyban A
    Pharmazie; 2007 Jan; 62(1):46-50. PubMed ID: 17294813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties, binary and ternary phase diagrams of ketoprofen.
    Hong Lu Y; Bun Ching C
    Chirality; 2004 Oct; 16(8):541-8. PubMed ID: 15290690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.